Can Propranolol for Anxiety Be Stopped?
Yes, propranolol used for anxiety can be stopped, but it should be tapered gradually over at least a few weeks rather than discontinued abruptly to avoid potential withdrawal effects, particularly rebound tachycardia and possible exacerbation of symptoms.
Key Considerations for Discontinuation
Tapering Approach
The FDA drug label explicitly warns against abrupt discontinuation, particularly noting concerns about exacerbation of angina and, in rare cases, myocardial infarction in cardiac patients 1. While these warnings primarily address cardiovascular indications, the principle of gradual withdrawal applies to anxiety treatment as well.
For anxiety disorders:
- Taper gradually over 1-3 weeks 2
- Monitor for rebound symptoms during the taper
- The specific tapering schedule should account for the dose being used and duration of treatment
Important Context: Limited Evidence Base
It's crucial to understand that propranolol lacks robust evidence for treating most anxiety disorders. A 2025 systematic review and meta-analysis found no evidence for beneficial effects of beta-blockers compared with placebo or benzodiazepines in patients with social phobia or panic disorder 3. An earlier 2016 meta-analysis similarly concluded that "the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders" 4.
When Propranolol May Be Appropriate
Propranolol shows some utility in specific, limited contexts:
- Performance anxiety/stage fright: Effective for acute situational anxiety with prominent somatic symptoms (tremor, palpitations), typically at low doses (20-40 mg) taken 1-2 hours before the event 5, 6
- Somatic symptoms of anxiety: Most effective when autonomic symptoms (tremor, palpitations) are prominent but not extreme 6
Discontinuation Safety
The good news: Unlike benzodiazepines, propranolol does not cause physical dependence or withdrawal seizures. The primary concerns with stopping are:
- Rebound tachycardia: The heart rate may temporarily increase above baseline
- Return of anxiety symptoms: The original symptoms will likely return, as propranolol addresses symptoms rather than underlying pathology
- Cardiovascular considerations: In patients with unrecognized coronary disease, abrupt cessation could theoretically precipitate cardiac events 1
Practical Discontinuation Protocol
Step 1: Assess the indication
- If used for performance anxiety only: Can stop after the event, though gradual taper over several days is still preferable
- If used chronically for generalized anxiety: Plan a structured taper
Step 2: Taper schedule (for chronic use)
- Reduce dose by 25-50% every 3-7 days
- Monitor heart rate and blood pressure during taper
- Watch for return of anxiety symptoms
Step 3: Consider alternative treatment
- Given the limited evidence for propranolol in anxiety disorders, discuss evidence-based alternatives (SSRIs, SNRIs, or cognitive behavioral therapy) 7, 3
Special Populations
Contraindications to be aware of (though these affect initiation more than discontinuation):
- Asthma or reactive airways disease
- Heart block greater than first degree
- Severe bradycardia
- Hypotension
- Heart failure 2, 1
Clinical Pitfall
The increasing prescription of beta-blockers for anxiety (substantially increased between 2003-2018) occurs despite lack of clinical guidance and robust evidence 3. Many patients may be on propranolol inappropriately. Discontinuation provides an opportunity to reassess the diagnosis and implement evidence-based treatment.
Bottom Line
Propranolol can and should be stopped when used for anxiety, using a gradual taper over 1-3 weeks to minimize rebound effects. However, the more important clinical question is whether it should have been started in the first place, given the limited evidence for its efficacy in most anxiety disorders. Discontinuation should prompt consideration of evidence-based alternatives like SSRIs, SNRIs, or cognitive behavioral therapy for sustained anxiety management.